Altered Innate-like T Cell Development in Vα14-Jα18 TCRα Transgenic Mice - Archive ouverte HAL Access content directly
Journal Articles ImmunoHorizons Year : 2020

Altered Innate-like T Cell Development in Vα14-Jα18 TCRα Transgenic Mice

(1) , (1) , (1) , (1) , (2) , (1)
1
2

Abstract

CD1d-restricted invariant NKT (iNKT) cells are innate-like T cells that respond to glycolipids, a class of Ags that are invisible to conventional T cells. iNKT cells develop in the thymus where they receive strong "agonist" TCR signals. During their ontogeny, iNKT cells differentiate into discrete iNKT1, iNKT2, and iNKT17 effector subsets akin to helper CD4 T cells. In this study, we found that transgenic (Tg) expression of the canonical Vα14-Jα18 TCRα-chain at the double-positive thymocyte stage led to premature iNKT cell development and a cell-intrinsic bias toward iNKT2 cells, due to increased TCR signaling upon selection. Consistent with the strong iNKT2 bias, innate memory CD8+ T cells were found in greater numbers in Vα14 Tg mice, whereas the prevalence of mucosa-associated invariant T cells was reduced. iNKT cells from Vα14 Tg mice were hyporesponsive to stimulation by their cognate Ag α-galactosylceramide. Finally, Vα14 Tg mice displayed increased B16F10 melanoma tumor growth compared with wild-type mice. This study reveals some of the limitations of Vα14 Tg mice and warrants the cautious interpretation of past and future findings using this mouse model.

Dates and versions

hal-03365042 , version 1 (05-10-2021)

Identifiers

Cite

Irene Lau, Carolina de Amat Herbozo, Meggie Kuypers, Qiaochu Lin, Christophe Paget, et al.. Altered Innate-like T Cell Development in Vα14-Jα18 TCRα Transgenic Mice. ImmunoHorizons , 2020, 4 (12), pp.797-808. ⟨10.4049/immunohorizons.2000100⟩. ⟨hal-03365042⟩
10 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More